The company’s new AI agent automates labor-intensive processes involved in trial document management.

AI and machine learning are revolutionizing drug discovery, development, and lifecycle management, addressing industry ...

Medable Inc., the leading technology platform for AI-powered clinical development, today announced its TMF Agent, which brings artificial intelligence and automation to the labor-intensive processes ...

YD BioMed expects to advance two lead ophthalmology programs utilizing its LSC Exosome platform, each supported by targeted regulatory and clinical milestones, which the timing of these milestones ...

Donald Trump’s destruction of the civil service is a tragedy not just for the roughly 300,000 workers who have been discarded ...

The DMTA cycle depends on clear data flow, yet most labs still work across disconnected systems. Sean McGee, Director of ...

Vice President JD Vance said the Trump administration is creating an assistant attorney general position to investigate ...

The LinkedIn cofounder and frequent Trump target has a simple message for his peers: “Just speak up about the things that you ...

Psyence Biomedical Ltd. ("Psyence BioMed" or the "Company"), a biopharmaceutical company advancing nature-derived psilocybin and ibogaine therapies for unmet mental health needs, today announced a ...

This important study, which tackles the challenge of analyzing genome integrity and instability in unicellular pathogens by introducing a novel single-cell genomics approach, presents compelling ...

Major stock indexes finished mixed Thursday, with the blue-chip Dow Jones Industrial Average rising but the tech-heavy Nasdaq ...

YDES YD Bio (NASDAQ:YDES) is an integrated biotechnology company that combines diagnostics, precision medicine, and regenerative ophthalmology under a single commercial and development strategy. The ...